The State of AI in Next-Generation R&D

As biologics pipelines expand and complexity rises, the need for smarter, faster innovation has never been greater. AI is poised to transform biologics R&D, not just by accelerating discovery, but by reimagining how we harness data to drive breakthroughs.

This session explores the bigger picture: what’s fuelling AI adoption, and what’s still holding it back. From siloed healthcare systems and unstructured data challenges to the growing demand for customised data sets, we’ll look at how forward-thinking organisations are overcoming these barriers to unlock more connected, adaptive, and intelligent R&D strategies.